Author(s)

Patrice Ntenga^1,2*, K. Kabulo³, Patrick Mutombo², A. Mulumba², E. Lowakondjo², Dirk Teuwen², Marième Soda Diop-Sène¹, A. A. Nahantchi¹, N. S. Diagne¹, K. Touré⁴, M. Ndiaye¹, A. Gallo Diop¹

¹Neurological Clinic of the National Teaching Hospital, FANN, Dakar, Senegal.
²Neuropsychiatric Center Joseph Guislain of the Brothers of Charity, Lubumbashi, Congo.
³Department of Neurosurgery, University of Zimbabwe, Harare, Zimbabwe.
⁴Department of Preventive Medicine and Public Health, Faculty of Medicine, Pharmacy and Odontostomatology, University of Cheikh Anta Diop, Dakar, Senegal.

Motor impairment of cerebral origin is a syndrome that induces a reduction in activity, the origin of which is brain injury or a non-progressive and definitive abnormality occurring in a developing immature brain. Motor disability, spastic, dyskinetic or ataxic, is often associated with sensory, cognitive, sensory and behavioral disorders with or without epileptic disease. View of accidental discoveries of corpus callosum abnormalities, most often asymptomatic or associated with psychomotor retardation, epilepsy, neurological disorders or cardiomyopathy, a high technical platform must be available for its diagnosis. We report in this article the case of a 7-year-old boy followed at the neuropsychiatric center Joseph Guislain of the Brothers of Charity of Lubumbashi in Congo (DRC) since 2016 for generalized tonic-clonic seizures, in whom the diagnosis of cerebral palsy on cyst of corpus callosum and in the right parietal lobe, as well as cardiopathy was posed during its consultation in September 2017. This case was published with parental consent.

Cerebral Palsy, Cyst of the Corpus Callosum, Parenchymal Cyst, Epilepsy, Heart Disease

Ntenga, P. , Kabulo, K. , Mutombo, P. , Mulumba, A. , Lowakondjo, E. , Teuwen, D. , Diop-Sène, M. , Nahantchi, A. , Diagne, N. , Touré, K. , Ndiaye, M. and Diop, A. (2018) Comorbidity of Cerebral Palsy, the Cyst of the Corpus Callosum, Parenchymal Cyst, Epilepsy and Cardiac Disease: About an Observation. Yangtze Medicine, 2, 39-45. doi: 10.4236/ym.2018.21004.